<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>39</viewCount><searchCount>0</searchCount></scores><additional><submitter>Ennis MA</submitter><funding>Canadian Institutes of Health Research</funding><funding>CIHR</funding><pagination>3224-3230</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7726121</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>150(12)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Phenylalanine and tyrosine (referred to as total aromatic amino acids; TAAs) are essential for protein synthesis, and are precursors for important catecholamines. Current estimated average requirement (EAR) recommendations for TAA during pregnancy are 36 mg·kg-1·d-1, and has not been experimentally determined.&lt;h4>Objectives&lt;/h4>The aim was to determine TAA requirements (dietary phenylalanine in the absence of tyrosine) during early and late gestation using the indicator amino acid oxidation (IAAO, with L-[1-13C]leucine) technique.&lt;h4>Methods&lt;/h4>Nineteen healthy pregnant women (age 22-38 y) were studied at a range of phenylalanine intakes (5 to 100 mg·kg-1·d-1) in early (13-19 wk) and/or late (33-39 wk) pregnancy for a total of 51 study days. Graded test intakes were provided as 8 hourly isonitrogenous and isocaloric meals. Breath samples were collected for 13C enrichment analysis on an isotope ratio mass spectrometer. A plasma sample was collected and analyzed for phenylalanine and tyrosine concentrations on an amino acid analyzer. The TAA requirement in early and late pregnancy was calculated using 2-phase linear regression crossover analysis that identified breakpoints in 13CO2 production (the requirement) in response to phenylalanine intakes.&lt;h4>Results&lt;/h4>TAA requirement during early pregnancy was 44 mg·kg-1·d-1 (95% CI: 28.3, 58.8) and during late pregnancy was 50 mg·kg-1·d-1 (95% CI: 36.1, 63.1). In early and late pregnancy, plasma phenylalanine and tyrosine concentrations rose linearly in response to graded phenylalanine intakes.&lt;h4>Conclusions&lt;/h4>Our results suggest that the current EAR of 36 mg·kg-1·d-1 for TAAs is underestimated. When compared with results previously determined in nonpregnant adults, early pregnancy requirements were similar (43 compared with 44 mg·kg-1·d-1, respectively). During late pregnancy, a 14% higher TAA requirement was observed when compared with early pregnancy. The results from this study have potential implications for creating gestation stage-specific TAA recommendations.</pubmed_abstract><journal>The Journal of nutrition</journal><pubmed_title>Dietary Aromatic Amino Acid Requirements During Early and Late Gestation in Healthy Pregnant Women.</pubmed_title><pmcid>PMC7726121</pmcid><funding_grant_id>FRN 10321</funding_grant_id><pubmed_authors>Ennis MA</pubmed_authors><pubmed_authors>Courtney-Martin G</pubmed_authors><pubmed_authors>Elango R</pubmed_authors><pubmed_authors>Ball RO</pubmed_authors><pubmed_authors>Lim K</pubmed_authors><pubmed_authors>Ong AJ</pubmed_authors><pubmed_authors>Pencharz PB</pubmed_authors><view_count>39</view_count></additional><is_claimable>false</is_claimable><name>Dietary Aromatic Amino Acid Requirements During Early and Late Gestation in Healthy Pregnant Women.</name><description>&lt;h4>Background&lt;/h4>Phenylalanine and tyrosine (referred to as total aromatic amino acids; TAAs) are essential for protein synthesis, and are precursors for important catecholamines. Current estimated average requirement (EAR) recommendations for TAA during pregnancy are 36 mg·kg-1·d-1, and has not been experimentally determined.&lt;h4>Objectives&lt;/h4>The aim was to determine TAA requirements (dietary phenylalanine in the absence of tyrosine) during early and late gestation using the indicator amino acid oxidation (IAAO, with L-[1-13C]leucine) technique.&lt;h4>Methods&lt;/h4>Nineteen healthy pregnant women (age 22-38 y) were studied at a range of phenylalanine intakes (5 to 100 mg·kg-1·d-1) in early (13-19 wk) and/or late (33-39 wk) pregnancy for a total of 51 study days. Graded test intakes were provided as 8 hourly isonitrogenous and isocaloric meals. Breath samples were collected for 13C enrichment analysis on an isotope ratio mass spectrometer. A plasma sample was collected and analyzed for phenylalanine and tyrosine concentrations on an amino acid analyzer. The TAA requirement in early and late pregnancy was calculated using 2-phase linear regression crossover analysis that identified breakpoints in 13CO2 production (the requirement) in response to phenylalanine intakes.&lt;h4>Results&lt;/h4>TAA requirement during early pregnancy was 44 mg·kg-1·d-1 (95% CI: 28.3, 58.8) and during late pregnancy was 50 mg·kg-1·d-1 (95% CI: 36.1, 63.1). In early and late pregnancy, plasma phenylalanine and tyrosine concentrations rose linearly in response to graded phenylalanine intakes.&lt;h4>Conclusions&lt;/h4>Our results suggest that the current EAR of 36 mg·kg-1·d-1 for TAAs is underestimated. When compared with results previously determined in nonpregnant adults, early pregnancy requirements were similar (43 compared with 44 mg·kg-1·d-1, respectively). During late pregnancy, a 14% higher TAA requirement was observed when compared with early pregnancy. The results from this study have potential implications for creating gestation stage-specific TAA recommendations.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Dec</publication><modification>2024-11-14T20:44:39.11Z</modification><creation>2022-02-11T12:51:22.093Z</creation></dates><accession>S-EPMC7726121</accession><cross_references><pubmed>33188409</pubmed><doi>10.1093/jn/nxaa317</doi></cross_references></HashMap>